Needles and needleless devices for infusion of anti-haemophilic factor concentrate: Impact on protein structure and function

Haemophilia

Volumn 12, Issue 1, 2006, Pages 58-61

  Prabhu, S ^a   Kazarian, T ^a   Hakobyan, N ^a   Jabbar, A ^a   Dunham, T ^b   Valentino, Leonard A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Baxter Bioscience   (United States)

Author keywords

Factor concentrate; Hemophilia; Intravenous infusion; Treatment

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROPHORETIC MOBILITY; GEL ELECTROPHORESIS; HEMOPHILIA; HUMAN; INTRAVENOUS ADMINISTRATION; NEEDLE; NEEDLESTICK INJURY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EQUIPMENT DESIGN; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INFUSIONS, INTRAVENOUS; MOLECULAR WEIGHT; NEEDLES; PEPTIDES;

EID: 33645978728     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01168.x     Document Type: Article

References (6)

1. Ewenstein B, Valentino LA, Journeycake JM et al. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia 2004; 10: 629-48.
2. Butler RB, McClure W, Wulff K. Practice patterns in haemophilia A therapy - a survey of treatment centres in the United States. Haemophilia 2003; 9: 549-54.
3. Vehar GA et al. Structure of human factor VIII. Nature 1984; 312: 337-42.
4. Østerud B et al. Human blood coagulation factor IX. J Biol Chem 1978; 253: 5946-51.
5. National Hemophilia Foundation, Medical and Scientific Advisory Council (MASAC). Recommendations, #35 and #17. 1993 and 2001: MASAC, New York.
6. Orenstein R. The benefits and limitations of needle protectors and needleless intravenous systems. J Intraven Nurs 1999; 22: 122-8.